Abstract
The African trypanosome, Trypanosoma brucei, is a protozoan that causes sleeping sickness in humans and Ngana in livestock. These flagellated parasites are directly exposed to immune defences as they circulate in the mammalian host bloodstream but they maintain persistent infections by undergoing antigenic variation. Central to this process is mono-allelic transcription and switching of the expressed variant-surface glycoprotein (VSG) gene which encodes the vast majority of their dense surface coat. The active telomeric VSG is transcribed by RNA polymerase I in an ‘expression site body’ (ESB) while transcription attenuation occurs at ‘inactive’ telomeres. Here, I review what is known about the molecular mechanisms involved in achieving antigenic variation and outline how we intend to exploit genome sequence and new tools, particularly RNA interference, to identify and characterise factors required for VSG regulation.
Keywords: antigenic variation, genome, rnai, trypanosoma brucei, vsg
Current Molecular Medicine
Title: The Molecular Control of Antigenic Variation in Trypanosoma brucei
Volume: 4 Issue: 6
Author(s): David Horn
Affiliation:
Keywords: antigenic variation, genome, rnai, trypanosoma brucei, vsg
Abstract: The African trypanosome, Trypanosoma brucei, is a protozoan that causes sleeping sickness in humans and Ngana in livestock. These flagellated parasites are directly exposed to immune defences as they circulate in the mammalian host bloodstream but they maintain persistent infections by undergoing antigenic variation. Central to this process is mono-allelic transcription and switching of the expressed variant-surface glycoprotein (VSG) gene which encodes the vast majority of their dense surface coat. The active telomeric VSG is transcribed by RNA polymerase I in an ‘expression site body’ (ESB) while transcription attenuation occurs at ‘inactive’ telomeres. Here, I review what is known about the molecular mechanisms involved in achieving antigenic variation and outline how we intend to exploit genome sequence and new tools, particularly RNA interference, to identify and characterise factors required for VSG regulation.
Export Options
About this article
Cite this article as:
Horn David, The Molecular Control of Antigenic Variation in Trypanosoma brucei, Current Molecular Medicine 2004; 4 (6) . https://dx.doi.org/10.2174/1566524043360078
DOI https://dx.doi.org/10.2174/1566524043360078 |
Print ISSN 1566-5240 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5666 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Concepts for Nano-delivery of Therapeutic Immunomodulatory Agents
Current Bionanotechnology (Discontinued) Drug-Loaded Nanocarriers in Tumor Targeted Drug Delivery
Current Biotechnology Anti-inflammatory Activity of Extra Virgin Olive Oil Polyphenols: Which Role in the Prevention and Treatment of Immune-Mediated Inflammatory Diseases?
Endocrine, Metabolic & Immune Disorders - Drug Targets Effects of Hydroxychloroquine on Progression of Diabetic Retinopathy in Subjects with Rheumatoid Arthritis and Type 2 Diabetes Mellitus
Current Diabetes Reviews Psoriasis and Vascular Risk : An Update
Current Pharmaceutical Design Cellular FLICE-Like Inhibitory Protein (C-FLIP): A Novel Target for Cancer Therapy
Current Cancer Drug Targets Ionic Liquid as a Green Media for the One-Pot Synthesis of New α- Thiazolodepsipeptide Derivatives via a Four-Component Reaction
Letters in Organic Chemistry MMP14 Regulates VEGFR3 Expression on Corneal Epithelial Cells
Protein & Peptide Letters Inflammation as a Therapeutic Target for Various Deadly Disorders: A Review
Current Drug Targets NF-κB as a Therapeutic Target for Transcription Factor Decoy Strategy in Inflammatory Diseases
Current Medicinal Chemistry - Anti-Inflammatory & Anti-Allergy Agents Patent Selections
Recent Patents on Regenerative Medicine Pharmaceutical Green Chemistry Applied to the Chemical Synthesis of Steroid Compounds
Current Green Chemistry The Physiological/Pathophysiological Significance of Vitamin D in Cancer, Cardiovascular Disorders and Beyond
Current Drug Metabolism Targeting of Antioxidant and Anti-Thrombotic Drugs to Endothelial Cell Adhesion Molecules
Current Pharmaceutical Design Novel Anti-Cancer Strategy in Bone Tumors by Targeting Molecular and Cellular Modulators of Bone Resorption
Recent Patents on Anti-Cancer Drug Discovery Anti-inflammatory strategies in stroke: a potential therapeutic target
Current Vascular Pharmacology Pathology and Development - Developmental Systems for Target Validation and Drug Screening in Osteoarthritis
Drug Design Reviews - Online (Discontinued) Skeletal Effects of Systemic and Topical Corticosteroids
Current Drug Safety Epigenetic Modifications Due to Heavy Metals Exposure in Children Living in Polluted Areas
Current Genomics Antibodies Against Complement System in SLE and their Potential Diagnostic Utility
Current Rheumatology Reviews